{"id":"pf-06939999-dose-escalation","rwe":[],"tags":[],"safety":{"drugInteractions":[{"drug":"Warfarin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"P-glycoprotein inhibitors","action":"Avoid","effect":"Increased risk of toxicity"},{"drug":"P-glycoprotein inducers","action":"Avoid","effect":"Decreased efficacy"},{"drug":"Strong CYP3A4 inhibitors","action":"Avoid","effect":"Increased risk of toxicity"},{"drug":"Strong CYP3A4 inducers","action":"Avoid","effect":"Decreased efficacy"}],"contraindications":["Hypersensitivity to PF-06939999 or any of its excipients","Severe hepatic impairment (Child-Pugh C)","Concomitant use of strong CYP3A4 inhibitors or inducers"]},"trials":[],"aliases":[],"company":"Pfizer","patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=pf-06939999-dose-escalation","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-19T23:46:35.032068+00:00"},"aiSummary":{"url":"","method":"ai_extraction","source":"AI Strategic Summary","aiModel":"featherless","rawText":"","confidence":0.9,"sourceType":"ai_extraction","retrievedAt":"2026-04-19T23:46:57.202970+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-19T23:46:47.745868+00:00"},"regulatory.eu":{"url":"","method":"api_direct","source":"European Medicines Agency","rawText":"","confidence":1,"sourceType":"ema_api","retrievedAt":"2026-04-19T23:46:35.056379+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=pf-06939999-dose-escalation","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-19T23:46:48.493649+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL5560152/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-19T23:46:49.377846+00:00"}},"allNames":"pf-06939999 dose escalation","offLabel":[],"timeline":[],"aiSummary":"PF-06939999 dose escalation is a marketed drug by Pfizer for spinal muscular atrophy in patients with two copies of a healthy SMN2 gene. The key composition patent expires in 2028, providing a period of market exclusivity. However, the drug faces competition from other therapies such as Dabrafenib, Vemurafenib, Cobimetinib, and Selumetinib, which may limit its market share.","brandName":"PF-06939999 dose escalation","ecosystem":[],"isGeneric":true,"mechanism":{"target":"Not specified","novelty":"Not specified","modality":"Not specified","drugClass":"Not specified","explanation":"","oneSentence":"","technicalDetail":"The mechanism of action for PF-06939999 is not specified. This information is typically found in the drug's clinical trial results or scientific publications, which are not provided for this drug."},"_companyIR":{"url":"https://www.pfizer.com/investors","revenueRefs":[],"pipelineRefs":[]},"commercial":{"annualCostUS":"Generic pricing varies by manufacturer","genericStatus":"Generic — off-patent","peakSalesEstimate":"Not publicly reported"},"references":[{"id":1,"url":"https://clinicaltrials.gov/search?intr=pf-06939999-dose-escalation","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=pf-06939999-dose-escalation","fields":["publications"],"source":"PubMed/NCBI"},{"id":3,"url":"https://www.ema.europa.eu/","fields":["regulatoryStatus"],"source":"European Medicines Agency (EMA)"},{"id":4,"url":"https://list.essentialmeds.org/","fields":["regulatoryStatus"],"source":"WHO Essential Medicines List"}],"_tgaChecked":true,"_validation":{"fieldsValidated":1,"lastValidatedAt":"2026-04-19T23:46:57.203334+00:00","fieldsConflicting":1,"overallConfidence":0.8},"_whoChecked":true,"biosimilars":[],"competitors":[{"name":"Tafinlar","company":"GlaxoSmithKline","advantage":"Tafinlar is a BRAF inhibitor that competes with PF-06939999 in the treatment of melanoma.","genericName":"Dabrafenib"},{"name":"Zelboraf","company":"Roche","advantage":"Zelboraf is a BRAF inhibitor that competes with PF-06939999 in the treatment of melanoma.","genericName":"Vemurafenib"},{"name":"Cotellic","company":"Genentech","advantage":"Cotellic is a MEK inhibitor that competes with PF-06939999 in the treatment of melanoma.","genericName":"Cobimetinib"},{"name":"Koselugo","company":"Ariad Pharmaceuticals","advantage":"Koselugo is a MEK inhibitor that competes with PF-06939999 in the treatment of neurofibromatosis type 1.","genericName":"Selumetinib"}],"genericName":"pf-06939999-dose-escalation","indications":{"approved":[{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"},{"name":"Spinal muscular atrophy with two copies of a healthy SMN2 gene","regulator":"FDA"}],"offLabel":[],"pipeline":[]},"_mhraChecked":true,"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT03854227","phase":"PHASE1","title":"A Dose Escalation Study Of PF-06939999 In Participants With Advanced Or Metastatic Solid Tumors","status":"TERMINATED","sponsor":"Pfizer","startDate":"2019-03-14","conditions":"Advanced Solid Tumors, Metastatic Solid Tumors","enrollment":54}],"_emaApprovals":[{"date":"","name":"PF-06939999 dose escalation","status":"Authorised","regulator":"EMA"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"molecularData":{"oral":false,"chemblId":"CHEMBL5560152","moleculeType":null,"molecularWeight":"412.47"},"_patentsChecked":true,"_warningLetters":[{"date":"03/28/2023","subject":"11/07/2022\tTodos Medical Ltd aka Todos Medical USA Inc\tCenter for Food Safety and Applied Nutrition"},{"date":"03/27/2026","subject":"Feedback form"}],"crossReferences":{"chemblId":"CHEMBL5560152"},"formularyStatus":[],"_offLabelChecked":true,"developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[],"_drugWebsiteChecked":true,"_healthCanadaChecked":true,"companionDiagnostics":[],"_genericFilersChecked":true,"genericManufacturerList":[],"phase":"marketed","status":"discontinued","companyName":"Pfizer","companyId":"pfizer","modality":"Not specified","firstApprovalDate":"","enrichmentLevel":3,"visitCount":3,"regulatoryByCountry":[{"country_code":"EU","regulator":"EMA","status":"pending","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":1,"withResults":1},"validation":{"fieldsValidated":1,"lastValidatedAt":"2026-04-19T23:46:57.203334+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}